Correlation of clinical and pathological staging and response to neoadjuvant therapy in resected pancreatic cancer

Clinical stage correlates poorly with pathological stage in resectable pancreatic cancer. The majority of patients do not experience a change in stage with NAT. Those with early stage disease, responsive to NAT, experience a survival benefit.